◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

HomeAll stocks › HIMS

Hims & Hers Health, Inc. (HIMS) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-07-09

Hims & Hers Health, Inc. (HIMS) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in San Francisco, United States with about 2,442 employees. Its market capitalization is roughly $8 billion. In the fiscal year ended 2025-12-31, HIMS reported $2.3B in revenue and $128M in net income.

Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and internationally.

Interactive charts & full statements → Open the HIMS valuation workbench →

HIMS Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Revenue$2.3B$1.5B$872M$527M
Gross Profit$1.7B$1.2B$715M$409M
Operating Income (EBIT)$106M$62M($30M)($69M)
Net Income$128M$126M($24M)($66M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

HIMS Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-03-312025-12-312025-09-302025-06-302025-03-31
Total Revenue$608M$618M$599M$545M$586M
Gross Profit$397M$444M$442M$416M$431M
Operating Income (EBIT)($78M)$9M$12M$27M$58M
Net Income($92M)$21M$16M$42M$50M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

HIMS Free Cash Flow History

HIMS Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Assets$2.2B$708M$441M$366M
Total Liabilities$1.6B$231M$97M$55M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive HIMS viewer.

Other Companies in Drug Manufacturers - Specialty & Generic

← HIIAll stocksHIND →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.